Contribute Try STAT+ Today

BOSTON — The biopharmaceutical sector in Massachusetts is growing so fast that companies are struggling to fill vacancies, particularly entry-level jobs that require an associate’s degree and those on the other end of the spectrum that require Ph.D.s, according to a new study.

Nearly 12,000 new jobs are expected to be created between mid-2017 and mid-2023, an increase of more than 17 percent, said the report by the nonprofit Massachusetts Biotechnology Education Foundation. That’s less than the 20.5 percent for the prior six years, but still robust.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.